For Your Health
For Your Health

News from the University of North Dakota School of Medicine & Health Sciences

DaCCoTA posts new RFAs for program grants

daccotaThe Dakota Cancer Collaborative on Translational Activity (DaCCoTA) has posted RFAs for two new pilot grants (feasibility and ready-to-go) and two other programs (DaCCoTA Scholars and Clinical Research Opportunities) offered through DaCCoTA. For more information about the programs summarized below, or any DaCCoTA program, see us online at: https://med.und.edu/daccota/.

  • The DaCCoTA Pilot Projects Program is requesting applications for Ready-to-Go Pilot Grant Awards. The goal of this DaCCoTA program is to stimulate growth of expertise and engagement in cancer-related clinical and translational research (CTR) in the Dakota region encompassed by the states of North and South Dakota. The mission of the Pilot Projects Program is to provide seed funding to highly innovative projects in clinical and translational cancer research. The Ready-to-Go Awards are intended for projects with significant preliminary data in support of a novel clinical/translational cancer-related hypothesis.
  • The DaCCoTA Clinical Translational Research (CTR) Scholars Program is a career development award that will provide early career investigators with up to 50 percent salary support as well as up to $50,000 to support their research efforts. These awards will be given to faculty at participating institutions (priority will be given to Assistant Professors) with the goal of helping them submit an R01 or equivalent grant proposal within 2-3 years and achieve funding within 3-4 years. Up to two (2) applications will be funded. Preference will be given to projects that are T2, T3, or T4. Projects that are T1 will be considered if they show a plan to progress to T2 or beyond.
  • The DaCCoTA Pilot Projects Program is requesting applications for Feasibility Pilot Grant Awards. The mission of the Pilot Projects Program is to provide seed funding for highly innovative projects in clinical and translational cancer research. The  Feasibility Awards are intended to provide support to allow a clinician/non-clinician team to form around a novel cancer-related hypothesis.
  • The DaCCoTA Clinical Translational Research (CTR) Clinical Research Opportunities Program provides funding for 20 percent release time for clinicians so they can participate in translational research. To begin to fulfill unmet needs in the area of clinical-translational research, community-practicing, hospital-based clinicians are invited to apply for training in means to participate in CTR. To begin to shift translational research in the upper-Midwest to an enterprise informed by the patient, the DaCCoTA Professional Development Core (PDC) is offering training to community-practicing, hospital-based clinicians. These clinicians will be provided with 20 percent release time of the NIH salary cap (currently $189,600) to allow participation in training activities and collaboration or consultation in CTR.